XOFIGO^® (radium‑ 223 dichlorid) v léčbě metastatického kastračně rezistentního karcinomu prostaty

Czech version

Published in: Klin Onkol 2013; 26(6): 440-441
Category: Oncology Highlights

Sources

1. Nilsson S, Larsen RH, Fosså SD et al. First clinical experience with alpha‑ emitting radium‑ 223 in the treatment of skeletal metastases. Clin Cancer Res 2005; 11(12): 4451– 4459.

2. Morris P et al. Presented at: ASCO Genitourinary Cancers Symposium 2010: abstr. 211.

3. Parker C, Nilsson S, Heinrich D et al. Alpha emitter radium‑ 223 and survival in metastatic prostate cancer. N Engl J Med 2013; 369(3): 213– 223.

4. Bruland ØS, Nilsson S, Fisher DR et al. High‑linear energy transfer irradiation targeted to skeletal metastases by the alpha‑ emitter 223Ra: adjuvant or alternative to conventional modalities? Clin Cancer Res 2006; 12(20 Pt 2): 6250– 6257.

5. Lewington V et al. Presented at: ASCO GU 2010: abstr. 216.

6. Morris P et al. Presented at: ASCO 2012: abstr. ID #TPS4694.

7. Parker C et al. Presented at: ESMO 2012: poster 898PD.